CLINICAL ROLE -
How Biomarkers Can Improve Early Diagnosis of Multiple Sclerosis
A lack of biomarkers can result in a delay in multiple sclerosis diagnosis and treatment.
Read More
Immunomodulatory Drugs May Boost Treatment of Late-Stage Multiple Sclerosis
The neurodegenerative phase of multiple sclerosis remains a significant challenge for researchers.
New Treatment Options Emerge for Tardive Dyskinesia
New FDA-approved drugs are members of a new class of vesicular monoamine transporter-2 inhibitors developed to address movement disorders.
Tardive Dyskinesia Drug Approval Illustrates Efficient Trial Design
FDA approval of valbenazine (Ingrezza) for the iatrogenic movement disorder tardive dyskinesia shows impact of a well-executed development program.
Many Patients with Age-Related Macular Degeneration Remain Undiagnosed After Eye Exam
Age-related macular degeneration (AMD) is the leading cause of irreversible vision loss in older people.
Resveratrol-based Nutraceutical Improves Symptoms of Age-Related Macular Degeneration
Dark adaptation testing has been shown to be better than visual acuity testing in diagnosing and staging AMD.
Weighing Treatments for Diabetic Macular Edema
Study weighs whether aflibercept (Eylea) is cost-effective compared with ranibizumab (Lucentis) in treating diabetic macular edema.
Safety Profile of Ranibizumab for Diabetic Macular Edema
Ranibizumab has been prescribed to treat more than 55,000 patients with diabetic macular edema.
Mechanisms of Rheumatoid Arthritis-Associated Interstitial Lung Disease
Interstitial lung disease, a common complication of rheumatoid arthritis, often leads to deteriorating health.
Uveitis Risk May be Elevated in Patients with Multiple Sclerosis
Conflicting evidence surrounds the association between multiple sclerosis and uveitis.
Ranibizumab Falls Short Stopping New Macular Atrophy in Neovascular AMD
Study shows a significant association between baseline foveal choroidal thickness and macular atrophy.
Ozurdex Shows Superiority Treating Diabetic Macular Edema
Anti-vascular endothelial growth factor agents are the criterion standard for diabetic macular edema.
Conflicting Evidence Over Stroke Risk from AMD Drug
Studies find varying results in incidence of strokes from wet age-related macular degeneration treatment.
Posterior Uveitis Drug Shows Improved Efficacy
Immunoregulatory agent sirolimus shows superiority to systemic corticosteroids in noninfectious uveitis.
Juvenile Idiopathic Arthritis Drug Shows Promise
Patients with severe refractory juvenile idiopathic arthritis-associated uveitis may achieve complete remission with tocilizumab.
Ozurdex Outperforms Avastin in Diabetic Macular Edema
Better Asthma Treatments for High Risk Patients Could Reduce Healthcare Costs
Healthcare resource use and costs related to eosinophil level in patients with asthma.
Tiotropium Boosts Lung Function in Adolescents with Moderate Asthma
Once-daily tiotropium added to ICS maintenance therapy found safe and effective in moderate symptomatic asthma.